CGTX

COGNITION THERAPEUTICS INC

Latest Form 4:Purchase$11KbyCaggiano Anthony (Chief Medical Officer) · filed Apr 20, 2026

COGNITION THERAPEUTICS INC (CGTX) has 19 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 22, 2026.

  • Industry:Biotechnology
  • CEO:Lisa Ricciardi
  • Employees:14
  • HQ:Purchase, NY, US
  • IPO:2021-10-08

Insider Buying

$32K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$97.0M

latest known value

Source
Caggiano AnthonyFirst filing
Purchase$11KApr 20SEC ↗
Ricciardi LisaFirst filing
Purchase$10KApr 20SEC ↗
Doyle John BrendanFirst filing
Purchase$11KApr 20SEC ↗

Related companies

COGNITION THERAPEUTICS INC is in the Healthcare sector.